Literature DB >> 11752122

3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics.

Cándido Hernández-López1, Magí Farré, Pere N Roset, Esther Menoyo, Nieves Pizarro, Jordi Ortuño, Marta Torrens, Jordi Camí, Rafael de La Torre.   

Abstract

3,4-Methylenedioxymethamphetamine (MDMA) is frequently consumed in association with alcohol. The effect of this combination in humans has not been previously investigated. Nine male healthy volunteers received single oral doses of 100 mg of MDMA plus 0.8 g/kg ethanol, 100 mg of MDMA, 0.8 g/kg of ethanol, and placebo in a double blind, double dummy, randomized crossover trial. Measurements included psychomotor performance, subjective effects, and pharmacokinetics. Plasma concentrations of MDMA showed a 13% increase after the use of alcohol, whereas plasma concentrations of alcohol showed a 9 to 15% decrease after MDMA administration. The MDMA-alcohol combination induced longer lasting euphoria and well being than MDMA or alcohol alone. MDMA reversed the subjective sedation induced by alcohol but did not reduce drunkenness feelings. MDMA did not reverse the actions of alcohol on psychomotor abilities. Combined use of MDMA and alcohol causes dissociation between subjective and objective sedation. Subjects may feel euphoric and less sedated and might have the feeling of doing better, but actual performance ability continues to be impaired by the effect of alcohol. Confirmation of these findings in further studies will be highly relevant in terms of road safety.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11752122     DOI: 10.1124/jpet.300.1.236

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  35 in total

1.  Dopaminergic system dysfunction in recreational dexamphetamine users.

Authors:  Anouk Schrantee; Lena Václavů; Dennis F R Heijtel; Matthan W A Caan; Willy Gsell; Paul J Lucassen; Aart J Nederveen; Jan Booij; Liesbeth Reneman
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

2.  Drinking and driving.

Authors:  James Maskalyk
Journal:  CMAJ       Date:  2003-02-04       Impact factor: 8.262

3.  MDMA: on the translation from rodent to human dosing.

Authors:  A Richard Green; Johan Gabrielsson; Charles A Marsden; Kevin C F Fone
Journal:  Psychopharmacology (Berl)       Date:  2009-01-13       Impact factor: 4.530

4.  Response to the comments by Cassel et al.

Authors:  G J H Dumont; R J Verkes; J K Buitelaar; J M A van Gerven
Journal:  Psychopharmacology (Berl)       Date:  2008-09-02       Impact factor: 4.530

5.  Ethanol and MDMA: a comment on the paper by Dumont et al.

Authors:  Jean-Christophe Cassel; Sami Ben Hamida; Byron C Jones
Journal:  Psychopharmacology (Berl)       Date:  2008-08-28       Impact factor: 4.530

Review 6.  Pharmacokinetic and pharmacodynamic drug interactions with ethanol (alcohol).

Authors:  Lingtak-Neander Chan; Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2014-12       Impact factor: 6.447

7.  The acute effects of MDMA and ethanol administration on electrophysiological correlates of performance monitoring in healthy volunteers.

Authors:  D B Spronk; G J H Dumont; R J Verkes; E R A De Bruijn
Journal:  Psychopharmacology (Berl)       Date:  2014-04-26       Impact factor: 4.530

8.  Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics.

Authors:  M Farré; R de la Torre; B O Mathúna; P N Roset; A M Peiró; M Torrens; J Ortuño; M Pujadas; J Camí
Journal:  Psychopharmacology (Berl)       Date:  2004-04-08       Impact factor: 4.530

9.  Drug interaction between ethanol and 3,4-methylenedioxymethamphetamine ("ecstasy").

Authors:  Vijay V Upreti; Natalie D Eddington; Kwan-Hoon Moon; Byoung-Joon Song; Insong J Lee
Journal:  Toxicol Lett       Date:  2009-04-05       Impact factor: 4.372

10.  Dose-related effects of MDMA on psychomotor function and mood before, during, and after a night of sleep loss.

Authors:  Wendy M Bosker; Kim P C Kuypers; Silke Conen; Johannes G Ramaekers
Journal:  Psychopharmacology (Berl)       Date:  2010-03       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.